Skip to main content
Ambu logo

Ambu — Investor Relations & Filings

Ticker · AMBU ISIN · DK0060946788 LEI · 5299008W2A69WX355710 CO Manufacturing
Open in API
Filings indexed 1,332 across all filing types
Latest filing 2019-08-22 M&A Activity
Country DK Denmark
Listing CO AMBU

About Ambu

https://www.ambu.com

Ambu is a global medical technology company that develops, manufactures, and markets single-use medical devices. A pioneer and market leader in single-use endoscopy, the company provides a broad portfolio of solutions for healthcare professionals across various clinical areas, including endoscopy, anesthesia, and patient monitoring. Its key products include the aScope™ line of single-use flexible endoscopes for pulmonology, gastroenterology, and urology, as well as video laryngoscopes. Ambu's solutions are designed to improve patient safety by eliminating the risk of cross-contamination associated with reusable devices, while also enhancing workflow efficiency in clinical environments by ensuring sterile, high-quality equipment is always available.

Recent filings

Filing Released Lang Actions
Ambu A/S: Ambu investerer i en 100% direkte salgs-organisation til pulmonologi i USA
M&A Activity Classification · 99% confidence The document is a short announcement (1811 chars) written in Danish. It details a strategic business decision by Ambu to take over the sales of aScope™ products from a US distributor (Tri-anim) and mentions that the financial expectations have changed. Crucially, it ends with the phrase: 'Læs mere i den vedhæftede selskabsmeddelelse' (Read more in the attached company announcement) and provides a link to a downloadable file named 'Selskabsmeddelelse nr. 13 2018_19'. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement that points to an attached or linked report is classified as a Report Publication Announcement (RPA). This is not the full financial report (10-K or IR) but the announcement of it.
2019-08-22 Danish
Earnings Release 2019
Earnings Release Classification · 99% confidence The document is very short (1775 characters) and announces a strategic business decision (transitioning to a direct sales organization in the US) and mentions that financial guidance is revised. Crucially, it ends with the statement, 'Read more in the attached company announcement,' and provides a link to an attachment labeled 'Company announcement no. 13 2018_19'. This structure—a brief summary announcing the availability of a more detailed document—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS), according to the 'MENU VS MEAL' rule. Since this is a specific business/strategic update rather than a standard financial report (like 10-K or IR), and it explicitly points to an attached announcement, RPA is the most appropriate classification for the announcement itself. FY 2019
2019-08-22 English
Earnings Release 2019
Earnings Release Classification · 99% confidence The document text is a formal announcement in Danish regarding a strategic business decision: Ambu is taking over the sales of its aScope™ products in the US market from its distributor, Tri-anim. Crucially, the document explicitly details the 'Indvirkning på finansielle forventninger for indeværende finansår (2018/19)' (Impact on financial expectations for the current fiscal year), listing specific reductions in revenue growth, unit sales, EBIT margin, and free cash flow. It also mentions compensation paid to the distributor and states that the effect on the 'Big Five 2020-strategien (2019/20)' will be disclosed with the Q3 2018/19 report on August 22, 2019. This structure—announcing a significant business event and immediately quantifying the resulting change in financial guidance—is characteristic of an Earnings Release (ER) or a major corporate announcement that updates guidance. Since it is not the full quarterly report (IR) or a transcript (CT), and it focuses on the immediate financial impact/revision of guidance, 'ER' (Earnings Release) is the most appropriate classification, even though the primary topic is M&A/distribution change, because the core function of this specific filing is to revise financial outlook. Q3 2019
2019-08-22 English
Ambu A/S: Ambu invests into a 100% direct sales organisation for pulmonology in the US
Regulatory Filings Classification · 95% confidence The document is a short announcement (under 2,000 characters) regarding a strategic business change (transitioning to a direct sales model in the US). It explicitly directs the reader to an 'attached' company announcement (Selskabsmeddelelse nr. 13 2018_19) via a link. Following the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA) as it serves to announce the availability of a formal filing rather than being the filing itself.
2019-08-22 English
Ambu A/S: Ambu invests into a 100% direct sales organisation for pulmonology in the US
Regulatory Filings Classification · 95% confidence The document is a company announcement (no. 13 2018/19) regarding a strategic shift to a direct sales organization in the US and a subsequent revision of financial guidance. While it discusses financial impacts, it is an announcement of a business strategy change and guidance update rather than a full financial report or a transcript. It fits best under 'Regulatory Filings' (RNS) as it is a formal company announcement regarding corporate strategy and guidance updates.
2019-08-22 English
Ambu A/S - Managers Transactions
Director's Dealing Classification · 100% confidence The document is titled 'Ambu A/S - Managers Transactions' and explicitly states that the CEO, Juan Jose Gonzalez, purchased shares. This is a standard disclosure of personal share transactions by a company executive, which falls under the 'Director's Dealing' category.
2019-06-25 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.